In homogeneous catalysis, the catalyst is in the same phase as the reactant. The number of collisions between reactants and catalyst is at a maximum.In a patent, 1532-71-4, name is 1-Bromoisoquinoline, introducing its new discovery. Formula: C9H6BrN
The invention relates to a can be useful as pharmaceutical intermediates of the formula shown in (III) of the method for synthesis of aryl ketone compound, said method comprising: in the nitrogen atmosphere and in organic solvent, in catalyst, oxidizing agent, in the presence of alkali and accelerant, the following formula (I) compounds and the following formula (II) compound generating reaction, after-treatment after reaction, so as to obtain the compound of said formula (III), wherein R 1-R 3 each independently selected from H, C 1-C 6 alkyl, C 1-C 6 alkoxy, halogen or nitro; X is halogen. The stated method, through appropriate selection of the substrate, and a catalyst is used, the oxidizing agent, alkali, accelerator and a reaction of the components of the organic solvent system, which can obtain the target product with high yield, for the kind of compound provides a new synthesis method, it has broad market application prospects. (by machine translation)
We’ll also look at important developments in the pharmaceutical industry because understanding organic chemistry is important in understanding health, medicine, the role of 1532-71-4, and how the biochemistry of the body works.Formula: C9H6BrN
Reference：
Isoquinoline – Wikipedia,
Isoquinoline | C9H2836N – PubChem